Avenir Wellness Solutions, Inc.
AVRW · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.03 | -0.00 | 0.57 |
| FCF Yield | -5.40% | -8.95% | -26.19% | -9.78% |
| EV / EBITDA | -20.87 | -14.80 | -8.87 | 309.57 |
| Quality | ||||
| ROIC | 13.64% | 22.96% | 34.97% | 47.04% |
| Gross Margin | 81.77% | 79.79% | 78.64% | 62.48% |
| Cash Conversion Ratio | 0.16 | 0.35 | 0.48 | 21.83 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.59% | 1,420,017.69% | 1,525,247.05% | 1,631,936.55% |
| Free Cash Flow Growth | 71.66% | 49.27% | -17.46% | 27.61% |
| Safety | ||||
| Net Debt / EBITDA | -17.59 | -10.61 | -6.96 | 187.14 |
| Interest Coverage | -26.47 | -119.17 | -124.43 | -50.27 |
| Efficiency | ||||
| Inventory Turnover | 0.25 | 0.38 | 0.55 | 2.12 |
| Cash Conversion Cycle | -5,924.53 | -3,292.91 | -2,068.43 | -367.57 |